Back to Journals » Clinical Ophthalmology » Volume 7

A case of 25 gauge vitrectomy for malignant glaucoma with microphthalmos

Authors Nakajima M, Hara Y, Yamazaki Y

Received 25 February 2013

Accepted for publication 9 April 2013

Published 31 May 2013 Volume 2013:7 Pages 1027—1029

DOI https://doi.org/10.2147/OPTH.S44488

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2



Masami Nakajima, Yusuke Hara, Yoshio Yamazaki

Department of Ophthalmology, Division of Visual Science, Nihon University School of Medicine, Tokyo, Japan

Abstract: We report the first case report of pars plana lensectomy (PPL) and pars plana vitrectomy using a 25 gauge vitrectomy system for microphthalmos.
Results: A 45-year-old woman reported repeated pain in her left eye, despite the use of medications. Ultrasound biomicroscopy revealed a narrow angle and thickened sclera. The lens and the iris showed anterior displacement with a flattening of the ciliary body. The axial length was 15.16 mm in the right eye and 15.04 mm in the left eye. She was diagnosed with a malignant glaucoma with microphthalmos. The patient underwent PPL and pars plana vitrectomy, using a 25 gauge vitrectomy system. The intraocular pressure was well controlled after surgery without medication.
Conclusion: We considered the PPL and 25 gauge vitrectomy effective in microphthalmos when performed safely.

Keywords: microphthalmos, aqueous misdirection, malignant glaucoma, ultrasound biomicroscopy, 25 gauge vitrectomy

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.